These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33464172)

  • 21. Bacterial lactoferrin-binding protein A binds to both domains of the human lactoferrin C-lobe.
    Wong H; Schryvers AB
    Microbiology (Reading); 2003 Jul; 149(Pt 7):1729-1737. PubMed ID: 12855724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenic neisseriae can use hemoglobin, transferrin, and lactoferrin independently of the tonB locus.
    Desai PJ; Garges E; Genco CA
    J Bacteriol; 2000 Oct; 182(19):5586-91. PubMed ID: 10986265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lactoferrin disruption of bacterial type III secretion systems.
    Ochoa TJ; Clearly TG
    Biometals; 2004 Jun; 17(3):257-60. PubMed ID: 15222474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LFchimera: a synthetic mimic of the two antimicrobial domains of bovine lactoferrin.
    Ligtenberg AJM; Bikker FJ; Bolscher JGM
    Biochem Cell Biol; 2021 Feb; 99(1):128-137. PubMed ID: 33560169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural biology of bacterial iron uptake.
    Krewulak KD; Vogel HJ
    Biochim Biophys Acta; 2008 Sep; 1778(9):1781-804. PubMed ID: 17916327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Component and functional mechanism of the ferrous iron acquisition system in gram-negative bacteria - A review].
    Feng Y; Liu M; Cheng A
    Wei Sheng Wu Xue Bao; 2016 Jul; 56(7):1061-9. PubMed ID: 29732873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of lactoferrin binding protein B in mediating protection against human lactoferricin.
    Morgenthau A; Livingstone M; Adamiak P; Schryvers AB
    Biochem Cell Biol; 2012 Jun; 90(3):417-23. PubMed ID: 22332888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antimicrobial activity of lactoferrin: current status and perspectives.
    Orsi N
    Biometals; 2004 Jun; 17(3):189-96. PubMed ID: 15222464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heme Uptake and Utilization by Gram-Negative Bacterial Pathogens.
    Richard KL; Kelley BR; Johnson JG
    Front Cell Infect Microbiol; 2019; 9():81. PubMed ID: 30984629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactoferrin-binding proteins in Bifidobacterium bifidum.
    Kim WS; Tanaka T; Kumura H; Shimazaki K
    Biochem Cell Biol; 2002; 80(1):91-4. PubMed ID: 11908648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of lactoferrin derived peptides on simulants of biological warfare agents.
    Sijbrandij T; Ligtenberg AJ; Nazmi K; Veerman EC; Bolscher JG; Bikker FJ
    World J Microbiol Biotechnol; 2017 Jan; 33(1):3. PubMed ID: 27832504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lactoferrin and Peptide-derivatives: Antimicrobial Agents with Potential Use in Nonspecific Immunity Modulation.
    Drago-Serrano ME; Campos-Rodriguez R; Carrero JC; de la Garza M
    Curr Pharm Des; 2018; 24(10):1067-1078. PubMed ID: 29589540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging strategies in microbial haem capture.
    Genco CA; Dixon DW
    Mol Microbiol; 2001 Jan; 39(1):1-11. PubMed ID: 11123683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial iron sources: from siderophores to hemophores.
    Wandersman C; Delepelaire P
    Annu Rev Microbiol; 2004; 58():611-47. PubMed ID: 15487950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to antimicrobial peptides in Gram-negative bacteria.
    Gruenheid S; Le Moual H
    FEMS Microbiol Lett; 2012 May; 330(2):81-9. PubMed ID: 22339775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are lactoferrin receptors in Gram-negative bacteria viable vaccine targets?
    Chan C; Andisi VF; Ng D; Ostan N; Yunker WK; Schryvers AB
    Biometals; 2018 Jun; 31(3):381-398. PubMed ID: 29767396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides.
    Bolscher JG; Adão R; Nazmi K; van den Keybus PA; van 't Hof W; Nieuw Amerongen AV; Bastos M; Veerman EC
    Biochimie; 2009 Jan; 91(1):123-32. PubMed ID: 18573310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potassium efflux induced by a new lactoferrin-derived peptide mimicking the effect of native human lactoferrin on the bacterial cytoplasmic membrane.
    Viejo-Díaz M; Andrés MT; Pérez-Gil J; Sánchez M; Fierro JF
    Biochemistry (Mosc); 2003 Feb; 68(2):217-27. PubMed ID: 12693969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiofilm activity of lactoferrin-derived synthetic peptides against
    Ramamourthy G; Vogel HJ
    Biochem Cell Biol; 2021 Feb; 99(1):138-148. PubMed ID: 32871093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application.
    Caccavo D; Pellegrino NM; Altamura M; Rigon A; Amati L; Amoroso A; Jirillo E
    J Endotoxin Res; 2002; 8(6):403-17. PubMed ID: 12542852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.